1. Home
  2. CVGI vs CNTX Comparison

CVGI vs CNTX Comparison

Compare CVGI & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commercial Vehicle Group Inc.

CVGI

Commercial Vehicle Group Inc.

HOLD

Current Price

$1.60

Market Cap

50.7M

ML Signal

HOLD

Logo Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

HOLD

Current Price

$1.05

Market Cap

102.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVGI
CNTX
Founded
2000
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.7M
102.9M
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
CVGI
CNTX
Price
$1.60
$1.05
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$5.40
AVG Volume (30 Days)
93.0K
485.5K
Earning Date
11-10-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$657,532,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.32
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.81
$0.49
52 Week High
$2.59
$1.61

Technical Indicators

Market Signals
Indicator
CVGI
CNTX
Relative Strength Index (RSI) 46.28 43.47
Support Level $1.57 $0.99
Resistance Level $1.67 $1.10
Average True Range (ATR) 0.09 0.08
MACD -0.01 -0.00
Stochastic Oscillator 25.00 24.37

Price Performance

Historical Comparison
CVGI
CNTX

About CVGI Commercial Vehicle Group Inc.

Commercial Vehicle Group Inc is a provider of systems, assemblies, and components to the commercial vehicle market and the electric vehicle markets. It delivers solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities. Its operating segments are Vehicle Solutions, Electrical Systems, and Aftermarket and Accessories. The company makes the majority of its revenue from Vehicle Solutions. The group generates revenue from its products including seating systems, plastic components, electrical wire harnesses, mirrors, wipers, and other accessories. Its geographic regions are North America, Europe and Asia-Pacific.

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: